Complete Story
09/22/2021
AMDA - The Society for PALTC Medicine | September 22
COMMERCIAL: COVID-19 Update
Headlines:
New/Updated Guidance
- CDC to Invest $2.1 Billion to Protect Patients and Healthcare Workers from COVID-19 and Future Infectious Diseases
- FDA authorizes bamlanivimab and etesevimab monoclonal antibody therapy for post-exposure prophylaxis (prevention) for COVID-19
- CDC: Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ?16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
Journal Articles/Preprints
- JAMDA: “Because if I don’t hold his hand then I might as well not be there”: Experiences of Dutch and UK care home visiting during the COVID-19 pandemic
- Ineffective neutralization of the SARS-CoV-2 Mu variant by convalescent and vaccine sera
- Association of Nursing Home Characteristics With Staff and Resident COVID-19 Vaccination Coverage
- Editor's Note: COVID-19 Vaccination Coverage Among Nursing Home Staff
- MMWR: Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ?18 Years — Long Beach, California, April 1–December 10, 2020
- JAMDA: Younger Individuals Increase Their Use of Nursing Homes Following ACA Medicaid Expansion
Research Reports/White Papers
- NIH builds large nationwide study population of tens of thousands to support research on long-term effects of COVID-19
- Dehydration plagues nursing home residents with COVID in facility study
- CDC: Residential Care Community Resident Characteristics: United States, 2018
Podcasts/Webinars
- TODAY: FMDA's Journal Club | The Thing About Boosters, September 22, 2021, 12:00 PM ET
- COVID-19 Monoclonal Antibody use in Post-acute, Long-term Care Settings
- CDC COCA: Evaluating and Supporting Patients Presenting With Fatigue Following COVID-19. Thursday, September 30, 2021. 2:00–3:00 PM ET
News/News Analysis
- $10.5 million AMDA, CDC partnership aims to improve vaccination rates in senior living, other settings
- CMS unveils new tool for public to compare nursing home vaccination rates
- Vaccine potency wanes, but third COVID shot restores 95 percent efficacy, new data show
- Use of religious vaccination exemptions could grow after judge blocks mandate
- An F.D.A. panel recommends authorizing Pfizer boosters for those over 65 or at high risk of severe Covid.
- Winter is coming, again: What to expect from Covid-19 as the season looms
- ‘Exceedingly difficult’ to control COVID inside facilities when virus rages outside, LTC experts find
- New COVID Variant With Unique Mutations Detected in Kentucky Nursing Home
